Trials / Completed
CompletedNCT00701662
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
A Multicentre Study of Subcutaneous Immunoglobulin (SCIG) in Patients With Multifocal Motor Neuropathy (MMN)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess efficacy, safety, and convenience of purified human antibodies administered under the skin in the treatment of MMN patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Vivaglobin |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2008-06-19
- Last updated
- 2013-08-01
- Results posted
- 2013-08-01
Locations
3 sites across 3 countries: Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00701662. Inclusion in this directory is not an endorsement.